MedTrace Logo

Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent Patients

NCT01828866 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2016-09-15

No results posted yet for this study

Summary

One interesting approach to the treatment of addiction is the use of Eye Movement Desensitization and Reprocessing (EMDR) (Shapiro, 1989). Although research on the feasibility and efficacy of EMDR on addiction is limited and often lacks methodological rigor, the results are promising and suggest that further research on this subject is warranted.

This proposal consists of two studies to test and determine the acceptability, feasibility and efficacy of EMDR as an intervention to reduce craving and alcohol use in alcohol dependent outpatients as well as to gain further understanding in underlying working mechanisms.

Conditions

  • Alcohol Dependence

Interventions

BEHAVIORAL

EMDR

EMDR is a protocolized, evidence-based treatment for PTSD. Here we use it to target addiction memory representations that elicit craving and may influence drinking behavior. The EMDR study protocol is based on the standard EMDR protocol and other EMDR approaches used in addiction.

BEHAVIORAL

Community Reinforcement Approach

CRA is based on behavioural therapy principles: 1. Functional analysis 2. Communication skills 3. Problem-solving skills 4. Sobriety sampling 5. Social networking 6. Refusal of substances 7. Reinforcing activities 8. Relapse management 9. Medication monitoring

Sponsors & Collaborators

  • Fonds Psychische Gezondheid

    collaborator OTHER

  • Dutch EMDR Association

    collaborator UNKNOWN

  • EMDR Research Foundation

    collaborator UNKNOWN

  • IrisZorg

    lead OTHER

Principal Investigators

  • Wiebren Markus, MSc · IrisZorg, NISPA, BSI (Radboud University)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01828866 on ClinicalTrials.gov